SELECTIVE-INHIBITION OF THE 12-LIPOXYGENASE PATHWAY OF ARACHIDONIC-ACID METABOLISM BY L-ARGININE OR SODIUM-NITROPRUSSIDE IN INTACT HUMAN PLATELETS

被引:44
作者
NAKATSUKA, M [1 ]
OSAWA, Y [1 ]
机构
[1] NHLBI,CHEM PHARMACOL LAB,BETHESDA,MD 20892
关键词
D O I
10.1006/bbrc.1994.1638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
L-arginine (1-100 mu M) or sodium nitroprusside (1-100 mu M) caused a concentration dependent decrease in the metabolism of exogenously added arachidonic acid via the 12-lipoxygenase pathway in intact human platelets, as determined by the use of an HPLC assay. N-G-monomethyl-L-arginine, but not the D-isomer of this compound, diminished the inhibitory effect of L-arginine. The D isomer of arginine had no effect. The cyclooxygenase pathway was much less susceptible to these effects. This study indicated that nitric oxide formed in intact human platelets selectively inhibited 12-lipoxygenase over that of cyclooxygenase and suggests that such inhibition may be an important regulatory mechanism. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1630 / 1634
页数:5
相关论文
共 33 条
[1]  
AHARONY D, 1984, LEUKOTRIENES, P103
[2]  
ANGGARD E, 1993, THERAPEUTIC APPLICAT, P1
[3]  
CROSET M, 1984, BIOMED BIOCHIM ACTA, V43, pS354
[4]   THE EFFECTS OF THE NITRIC-OXIDE DONORS MOLSIDOMINE AND SIN-I ON HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION-INVITRO AND EXVIVO [J].
DARIUS, H ;
GRODZINSKA, L ;
MEYER, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (06) :629-633
[5]  
DARIUS H, 1984, J CARDIOVASC PHARM, V6, P115
[6]  
DRAPIER JC, 1991, J BIOL CHEM, V266, P10162
[7]  
FITZGERALD GA, 1987, FASEB J, V46, P154
[8]   12-HETE INHIBITS THE BINDING OF PGH2 TXA2 RECEPTOR LIGANDS IN HUMAN PLATELETS [J].
FONLUPT, P ;
CROSET, M ;
LAGARDE, M .
THROMBOSIS RESEARCH, 1991, 63 (02) :239-248
[9]   12(R)-HYDROXYEICOSATETRAENOIC AND 12(S)-HYDROXYEICOSATETRAENOIC ACIDS - CHEMISTRY, BIOLOGY AND PHARMACOLOGY [J].
FRETLAND, DJ ;
DJURIC, SW .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1989, 38 (04) :215-228
[10]  
GASSAMADIAGNE A, 1992, J LIPID MEDIATOR, V5, P61